Moore RD - Search Results

1

Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.

Moore RD, Chaulk CP, Griffiths R, Cavalcante S, Chaisson RE. Moore RD, et al. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1013-9. doi: 10.1164/ajrccm.154.4.8887600. Am J Respir Crit Care Med. 1996. PMID: 8887600

2

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Gallant JE, et al. Among authors: moore rd. J Infect Dis. 1992 Dec;166(6):1223-7. doi: 10.1093/infdis/166.6.1223. J Infect Dis. 1992. PMID: 1358986

3

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Chaisson RE, et al. Among authors: moore rd. Am Rev Respir Dis. 1992 Aug;146(2):285-9. doi: 10.1164/ajrccm/146.2.285. Am Rev Respir Dis. 1992. PMID: 1362634

4

Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.

Chaisson RE, Keruly J, Richman DD, Moore RD. Chaisson RE, et al. Among authors: moore rd. Arch Intern Med. 1992 Oct;152(10):2009-13. Arch Intern Med. 1992. PMID: 1417373

5

Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.

Moore RD, Keruly J, Richman DD, Creagh-Kirk T, Chaisson RE. Moore RD, et al. AIDS. 1992 Jul;6(7):671-7. AIDS. 1992. PMID: 1503686 Clinical Trial.

6

Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group.

Moore RD, Creagh-Kirk T, Keruly J, Link G, Wang MC, Richman D, Chaisson RE. Moore RD, et al. Arch Intern Med. 1991 May;151(5):981-6. Arch Intern Med. 1991. PMID: 1673837 Clinical Trial.

7

Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography.

Steinberg EP, Moore RD, Powe NR, Gopalan R, Davidoff AJ, Litt M, Graziano S, Brinker JA. Steinberg EP, et al. Among authors: moore rd. N Engl J Med. 1992 Feb 13;326(7):425-30. doi: 10.1056/NEJM199202133260701. N Engl J Med. 1992. PMID: 1732769 Free article. Clinical Trial.

8

Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.

Easterbrook PJ, Keruly JC, Creagh-Kirk T, Richman DD, Chaisson RE, Moore RD. Easterbrook PJ, et al. Among authors: moore rd. JAMA. 1991 Nov 20;266(19):2713-8. JAMA. 1991. PMID: 1942423

9

Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine.

Moore RD, Kessler H, Richman DD, Flexner C, Chaisson RE. Moore RD, et al. JAMA. 1991 May 1;265(17):2208-11. JAMA. 1991. PMID: 2013953

10

Zidovudine and the natural history of the acquired immunodeficiency syndrome.

Moore RD, Hidalgo J, Sugland BW, Chaisson RE. Moore RD, et al. N Engl J Med. 1991 May 16;324(20):1412-6. doi: 10.1056/NEJM199105163242006. N Engl J Med. 1991. PMID: 2020297 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters